yesterday) and news out after the close that Valeant & Pershing Square are teaming up to make a run at Allergan (AGN +21% after the close). And now Novartis & GSK have announced a major series of transactions: creating new consumer-health venture (GSK 63.5% controlling interest), Novartis agrees to buy GSK's o